(ii) Pharmacologic inhibition of SLC25A1 by BTA reduced cellular antioxidant capacity, enhanced the generation of mitochondrial ROS and abrogated the increase in radioresistance of lung cancer cells induced by adaptation to chronic cycling severe hypoxia. The gene discussed is SLC25A1; the disease is lung cancer.